Inhibition of NF-κB activation by arsenite through reaction with a critical cysteine in the activation loop of IκB kinase

被引:302
作者
Kapahi, P
Takahashi, T
Natoli, G
Adams, SR
Chen, Y
Tsien, RY
Karin, M
机构
[1] Univ Calif San Diego, Dept Pharmacol 0636, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Howard Hughes Med Inst 0647, La Jolla, CA 92093 USA
关键词
D O I
10.1074/jbc.M007204200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Arsenite is a potent environmental toxin that causes various pathologies including cancers and skin disorders. Arsenite is believed to exert its biological effects through reaction with exposed sulfhydryl groups, especially pairs of adjacent thiols. Here, we describe the mechanism by which arsenite affects the NF-kappaB signaling pathway. Activation of transcription factor NF-kappaB depends on the integrity of the I kappaB kinase (IKK) complex. We found that arsenite potently inhibits NF-kappaB and IKK activation by binding to Cys-179 in the activation loop of the IKK catalytic subunits, IKK alpha/beta. The affinity of IKK beta for trivalent arsenic was verified in vitro by the ability of IKK beta to enhance the fluorescence of an arsenic-substituted fluorescein dye. The addition of 1,2-dithiol antidotes or replacement of Cys-179 with an alanine residue abolished dye binding to and arsenite inhibition of IKK beta. Overexpression of IKK beta (C179A) protects NF-kappaB from inhibition by arsenite, indicating that despite the involvement of a large number of distinct gene products in this activation pathway, the critical target for inhibition by arsenite is on the IKK catalytic subunits.
引用
收藏
页码:36062 / 36066
页数:5
相关论文
共 29 条
  • [1] Arsenic: Health effects, mechanisms of actions, and research issues
    Abernathy, CO
    Liu, YP
    Longfellow, D
    Aposhian, HV
    Beck, B
    Fowler, B
    Goyer, R
    Menzer, R
    Rossman, T
    Thompson, C
    Waalkes, M
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1999, 107 (07) : 593 - 597
  • [2] The NF-kappa B and I kappa B proteins: New discoveries and insights
    Baldwin, AS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 649 - 683
  • [3] Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases
    Barnes, PJ
    Larin, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) : 1066 - 1071
  • [4] The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase
    Cavigelli, M
    Li, WW
    Lin, AN
    Su, B
    Yoshioka, K
    Karin, M
    [J]. EMBO JOURNAL, 1996, 15 (22) : 6269 - 6279
  • [5] MEDICINAL ARSENIC AND INTERNAL MALIGNANCIES
    CUZICK, J
    EVANS, S
    GILLMAN, M
    EVANS, DAP
    [J]. BRITISH JOURNAL OF CANCER, 1982, 45 (06) : 904 - 911
  • [6] ARSENIC IN GROUND-WATER IN 6 DISTRICTS OF WEST-BENGAL, INDIA - THE BIGGEST ARSENIC CALAMITY IN THE WORLD .2. ARSENIC CONCENTRATION IN DRINKING-WATER, HAIR, NAILS, URINE, SKIN-SCALE AND LIVER-TISSUE (BIOPSY) OF THE AFFECTED PEOPLE
    DAS, D
    CHATTERJEE, A
    MANDAL, BK
    SAMANTA, G
    CHAKRABORTI, D
    CHANDA, B
    [J]. ANALYST, 1995, 120 (03) : 917 - 924
  • [7] Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation
    Delhase, M
    Hayakawa, M
    Chen, Y
    Karin, M
    [J]. SCIENCE, 1999, 284 (5412) : 309 - 313
  • [8] A cytokine-responsive I kappa B kinase that activates the transcription factor NF-kappa B
    DiDonato, JA
    Hayakawa, M
    Rothwarf, DM
    Zandi, E
    Karin, M
    [J]. NATURE, 1997, 388 (6642) : 548 - 554
  • [9] HISTORY OF THE TREATMENT OF PSORIASIS
    FARBER, EM
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 27 (04) : 640 - 645
  • [10] Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors
    Gray, NS
    Wodicka, L
    Thunnissen, AMWH
    Norman, TC
    Kwon, SJ
    Espinoza, FH
    Morgan, DO
    Barnes, G
    LeClerc, S
    Meijer, L
    Kim, SH
    Lockhart, DJ
    Schultz, PG
    [J]. SCIENCE, 1998, 281 (5376) : 533 - 538